A.G. Scientific, Inc. (R,S)-Lenalidomide L-2170

Description
Cell-permeable. An analog of thalidomide that was originally found based on its ability to effectively inhibit tumor necrosis factor production. Lenalidomide is 50,000 times more potent than thalidomide in inhibiting Tumor Necrosis Factor-α (TNF-α). Displays potent anti-tumor and anti-inflammatory effects as well as modulates and potentiates host immune responses against multiple myeloma.
Description
Cell-permeable. An analog of thalidomide that was originally found based on its ability to effectively inhibit tumor necrosis factor production. Lenalidomide is 50,000 times more potent than thalidomide in inhibiting Tumor Necrosis Factor-α (TNF-α). Displays potent anti-tumor and anti-inflammatory effects as well as modulates and potentiates host immune responses against multiple myeloma.

Suppliers

Company
Product
Description
Supplier Links
San Diego, CA, USA
(R,S)-Lenalidomide
L-2170
(R,S)-Lenalidomide L-2170
Cell-permeable. An analog of thalidomide that was originally found based on its ability to effectively inhibit tumor necrosis factor production. Lenalidomide is 50,000 times more potent than thalidomide in inhibiting Tumor Necrosis Factor-α (TNF-α). Displays potent anti-tumor and anti-inflammatory effects as well as modulates and potentiates host immune responses against multiple myeloma.

Cell-permeable. An analog of thalidomide that was originally found based on its ability to effectively inhibit tumor necrosis factor production. Lenalidomide is 50,000 times more potent than thalidomide in inhibiting Tumor Necrosis Factor-α (TNF-α).
Displays potent anti-tumor and anti-inflammatory effects as well as modulates and potentiates host immune responses against multiple myeloma.

Supplier's Site

Technical Specifications

  A.G. Scientific, Inc.
Product Category Biological Materials
Product Number L-2170
Product Name (R,S)-Lenalidomide
Unlock Full Specs
to access all available technical data

Similar Products